Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder
暂无分享,去创建一个
R. Tancredi | F. Muratori | S. Calderoni | A. Gastaldelli | M. Morales | L. Guiducci | D. Peroni | M. Gaggini | Margherita Prosperi | Chiara Narducci | E. Santocchi | C. Narducci | Elisa Santocchi
[1] Stefan N Hansen,et al. Association of Genetic and Environmental Factors With Autism in a 5-Country Cohort. , 2019, JAMA psychiatry.
[2] S. Bölte,et al. Towards a consensus on developmental regression , 2019, Neuroscience & Biobehavioral Reviews.
[3] Karen L. Jones,et al. An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study , 2019, Biological Psychiatry.
[4] N. Rezaei,et al. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. , 2019, Journal of psychiatric research.
[5] S. Bölte,et al. Regression in autism spectrum disorder: A critical overview of retrospective findings and recommendations for future research , 2019, Neuroscience & Biobehavioral Reviews.
[6] G. Thompson,et al. Cytokines and Chemokines in Pediatric Appendicitis: A Multiplex Analysis of Inflammatory Protein Mediators , 2019, Mediators of inflammation.
[7] A. K. Datusalia,et al. Metabolic Stress and Inflammation: Implication in Treatment for Neurological Disorders. , 2018, CNS & neurological disorders drug targets.
[8] M. Gil-Campos,et al. Children With Autism Spectrum Disorder With Regression Exhibit a Different Profile in Plasma Cytokines and Adhesion Molecules Compared to Children Without Such Regression , 2018, Front. Pediatr..
[9] I. Hertz-Picciotto,et al. Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms , 2018, Brain, Behavior, and Immunity.
[10] D. Gibson,et al. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines , 2018, Front. Immunol..
[11] K. Hozyasz,et al. Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment? , 2018, Molecular Neurobiology.
[12] Edmond J. Breen,et al. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder , 2017, Molecular Autism.
[13] R. Igliozzi,et al. Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity , 2017, Journal of autism and developmental disorders.
[14] J. Piven,et al. Toward a conceptual framework for early brain and behavior development in autism , 2017, Molecular Psychiatry.
[15] K. Kendrick,et al. Immunological cytokine profiling identifies TNF-α as a key molecule dysregulated in autistic children , 2017, Oncotarget.
[16] K. Kendrick,et al. Immunological cytokine profiling identifies TNF-α as a key molecule dysregulated in autistic children , 2017, Oncotarget.
[17] S. Pentyala,et al. Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels , 2017, International journal of inflammation.
[18] D. Amaral,et al. Immune Endophenotypes in Children With Autism Spectrum Disorder , 2017, Biological Psychiatry.
[19] X. Liao,et al. Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study. , 2017, The Tohoku journal of experimental medicine.
[20] J. Leckman,et al. Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders , 2017, Revista brasileira de psiquiatria.
[21] D. Siniscalco,et al. Peripheral Inflammatory Markers Contributing to Comorbidities in Autism , 2016, Behavioral sciences.
[22] M. Ghaffari,et al. Increased Serum Levels of Tumor Necrosis Factor-Alpha, Resistin, and Visfatin in the Children with Autism Spectrum Disorders: A Case-Control Study , 2016, Neurology research international.
[23] Bradley J. Ferguson,et al. Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder , 2016, Brain, Behavior, and Immunity.
[24] A. Teixeira,et al. Early changes in adipokines from overweight to obesity in children and adolescents. , 2016, Jornal de pediatria.
[25] J. Rogers,et al. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years. , 2016, Journal of Alzheimer's disease : JAD.
[26] L. Billeci,et al. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters , 2016, BMC Psychiatry.
[27] Alessandra Retico,et al. Temporal lobe connects regression and macrocephaly to autism spectrum disorders , 2015, European Child & Adolescent Psychiatry.
[28] P. Ashwood,et al. Evidence supporting an altered immune response in ASD. , 2015, Immunology letters.
[29] D. Pennington,et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.
[30] E. Sullivan,et al. The impact of leptin on perinatal development and psychopathology , 2014, Journal of Chemical Neuroanatomy.
[31] X. Ming,et al. Gastrointestinal Dysfunction in Children With Autism Spectrum Disorders , 2014, Autism research : official journal of the International Society for Autism Research.
[32] A. Guastella,et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis , 2014, Molecular Psychiatry.
[33] B. Goldstein,et al. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[34] J. Kern,et al. Evaluation of regression in autism spectrum disorder based on parental reports , 2014, North American journal of medical sciences.
[35] A. Kummer,et al. Changes in Adipokine Levels in Autism Spectrum Disorders , 2013, Neuropsychobiology.
[36] D. Amaral,et al. Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors , 2013, Brain, Behavior, and Immunity.
[37] H. Kwon,et al. Adipokines Mediate Inflammation and Insulin Resistance , 2013, Front. Endocrinol..
[38] Jason J. Corneveaux,et al. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder , 2013, Journal of Neuroinflammation.
[39] D. Coury,et al. Gastrointestinal Conditions in Children With Autism Spectrum Disorder , 2012 .
[40] S. Furth,et al. Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort. , 2012, The Journal of pediatrics.
[41] K. Suk,et al. Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity , 2012, Journal of Neuroinflammation.
[42] A. Sheikh,et al. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. , 2012, Biochimica et biophysica acta.
[43] Pat Levitt,et al. Gastrointestinal Dysfunction in Autism: Parental Report, Clinical Evaluation, and Associated Factors , 2012, Autism research : official journal of the International Society for Autism Research.
[44] J. Morillas-Ruiz,et al. A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.
[45] K. Alysandratos,et al. Mast cell activation and autism. , 2012, Biochimica et biophysica acta.
[46] Deana D. Li,et al. Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders , 2011, Proceedings of the National Academy of Sciences.
[47] I. Hertz-Picciotto,et al. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders , 2011, Journal of Neuroimmunology.
[48] Paula Krakowiak,et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome , 2011, Brain, Behavior, and Immunity.
[49] P. Ashwood,et al. Immune dysfunction in autism: A pathway to treatment , 2010, Neurotherapeutics.
[50] Gina G. Turrigiano,et al. Tumor Necrosis Factor-α Signaling Maintains the Ability of Cortical Synapses to Express Synaptic Scaling , 2010, The Journal of Neuroscience.
[51] A. Auteri,et al. Variations of plasma leptin and adiponectin levels in autistic patients , 2010, Neuroscience Letters.
[52] P. Ashwood,et al. Differential monocyte responses to TLR ligands in children with autism spectrum disorders , 2010, Brain, Behavior, and Immunity.
[53] M. Lyte,et al. Stress at the intestinal surface: catecholamines and mucosa–bacteria interactions , 2010, Cell and Tissue Research.
[54] J. Bastard,et al. The role of interleukins in insulin resistance and type 2 diabetes mellitus , 2009, Nature Reviews Endocrinology.
[55] A. Auteri,et al. Long‐term plasma levels of leptin and adiponectin in Rett syndrome , 2009, Clinical endocrinology.
[56] I. Hertz-Picciotto,et al. Brief Report: Plasma Leptin Levels are Elevated in Autism: Association with Early Onset Phenotype? , 2008, Journal of autism and developmental disorders.
[57] Paula Krakowiak,et al. Regression in autism: prevalence and associated factors in the CHARGE Study. , 2008, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.
[58] W. Pan,et al. Adipokines and the blood-brain barrier , 2007, Peptides.
[59] Dennis R. Dixon,et al. Adaptive Behavior Scales , 2007 .
[60] J. Ranger-Moore,et al. Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study , 2006, Journal of autism and developmental disorders.
[61] P. Ashwood,et al. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms , 2006, Journal of Neuroimmunology.
[62] Jacqueline Capeau,et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.
[63] Brigitte M. Kudielka,et al. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men , 2006, Brain, Behavior, and Immunity.
[64] C. Härtel,et al. Cytokine responses correlate differentially with age in infancy and early childhood , 2005, Clinical and experimental immunology.
[65] Barbie Zimmerman-Bier,et al. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. , 2005, The Journal of pediatrics.
[66] A. Zimmerman,et al. Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.
[67] P. Ashwood,et al. Spontaneous Mucosal Lymphocyte Cytokine Profiles in Children with Autism and Gastrointestinal Symptoms: Mucosal Immune Activation and Reduced Counter Regulatory Interleukin-10 , 2004, Journal of Clinical Immunology.
[68] H. Tilg,et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. , 2003, Biochemical and biophysical research communications.
[69] R Day,et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism , 2002, Molecular Psychiatry.
[70] S. Puglisi‐Allegra,et al. No association between the 4g/5G polymorphism of the plasminogen activator inhibitor-1 gene promoter and autistic disorder. , 2001, Psychiatric genetics.
[71] R Day,et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.
[72] S. Akira,et al. Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation , 2001, The Journal of experimental medicine.
[73] M H Lewis,et al. Varieties of Repetitive Behavior in Autism: Comparisons to Mental Retardation , 2000, Journal of autism and developmental disorders.